Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 1-Common Sarcomas: From the Radiologic Pathology Archives.

Levy AD, Manning MA, Al-Refaie WB, Miettinen MM.

Radiographics. 2017 Mar-Apr;37(2):462-483. doi: 10.1148/rg.2017160157.

PMID:
28287938
2.

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas.

Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T.

Onco Targets Ther. 2017 Feb 23;10:1155-1164. doi: 10.2147/OTT.S127955. eCollection 2017. Review.

3.

Recent advances in the management of liposarcoma.

Nassif NA, Tseng W, Borges C, Chen P, Eisenberg B.

F1000Res. 2016 Dec 22;5:2907. doi: 10.12688/f1000research.10050.1. eCollection 2016. Review.

4.

Plasma levels of miRNA-155 as a powerful diagnostic marker for dedifferentiated liposarcoma.

Boro A, Bauer D, Born W, Fuchs B.

Am J Cancer Res. 2016 Jan 15;6(2):544-52. eCollection 2016.

5.

Integrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic Value.

Cheng C, Lou S, Andrews EH, Ung MH, Varn FS.

Mol Cancer Res. 2016 Apr;14(4):332-43. doi: 10.1158/1541-7786.MCR-15-0368. Epub 2016 Feb 8.

6.

Deregulation of dicer and mir-155 expression in liposarcoma.

Vincenzi B, Iuliani M, Zoccoli A, Pantano F, Fioramonti M, De Lisi D, Frezza AM, Rabitti C, Perrone G, Onetti Muda A, Russo A, Giordano A, Santini D, Dei Tos AP, Tonini G.

Oncotarget. 2015 Apr 30;6(12):10586-91.

7.

Occurrence of colonic liposarcoma after retroperitoneal liposarcoma.

Choi JH, Hwang IG, Cha SJ, Lee TJ, Jang JS.

Korean J Intern Med. 2015 Jan;30(1):125-8. doi: 10.3904/kjim.2015.30.1.125. Epub 2014 Dec 30. No abstract available.

8.

Primary pleural liposarcoma, pleomorphic variant.

Carrillo B JA, Navarrete C, López Arias MA, Peláez M.

J Thorac Dis. 2014 Sep;6(9):E166-8. doi: 10.3978/j.issn.2072-1439.2014.07.30.

9.

Small bowel pleomorphic liposarcoma: a rare cause of gastrointestinal bleeding.

Nennstiel S, Mollenhauer M, Schlag C, Becker V, Neu B, Hüser N, Gertler R, Schmid RM, von Delius S.

Case Rep Gastrointest Med. 2014;2014:391871. doi: 10.1155/2014/391871. Epub 2014 Aug 4.

10.

Combined cutaneous sarcoma: pleomorphic liposarcoma and conventional osteosarcoma-the so-called malignant mesenchymoma.

Parada D, Peña KB.

Case Rep Pathol. 2012;2012:749898. doi: 10.1155/2012/749898. Epub 2012 Oct 2.

11.

Pleomorphic liposarcoma: clinical observations and molecular variables.

Ghadimi MP, Liu P, Peng T, Bolshakov S, Young ED, Torres KE, Colombo C, Hoffman A, Broccoli D, Hornick JL, Lazar AJ, Pisters P, Pollock RE, Lev D.

Cancer. 2011 Dec 1;117(23):5359-69. doi: 10.1002/cncr.26195. Epub 2011 May 19.

12.

Epithelioid variant of pleomorphic liposarcoma as potential mimic of metastatic carcinoma.

D'Antonio A, Angrisani B, Caleo A, Baldi C, Liguori G, Memoli D, Cuomo R, Angrisani P.

Rare Tumors. 2011 Mar 30;3(1):e10. doi: 10.4081/rt.2011.e10.

13.

Liposarcoma in children and young adults: a multi-institutional experience.

Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, Wang WL, Barahmani N, Okcu MF, Hicks J, Debelenko L, Spunt SL.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1142-6. doi: 10.1002/pbc.23095. Epub 2011 Mar 10.

14.

Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis.

Gobble RM, Qin LX, Brill ER, Angeles CV, Ugras S, O'Connor RB, Moraco NH, Decarolis PL, Antonescu C, Singer S.

Cancer Res. 2011 Apr 1;71(7):2697-705. doi: 10.1158/0008-5472.CAN-10-3588. Epub 2011 Feb 18.

15.

Liposarcoma: molecular genetics and therapeutics.

Conyers R, Young S, Thomas DM.

Sarcoma. 2011;2011:483154. doi: 10.1155/2011/483154. Epub 2010 Dec 27.

16.

Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.

Nishida Y, Tsukushi S, Nakashima H, Ishiguro N.

Clin Orthop Relat Res. 2010 Nov;468(11):3041-6. doi: 10.1007/s11999-010-1396-3.

17.

Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.

de Vreeze RS, de Jong D, Nederlof PM, Ariaens A, Tielen IH, Frenken L, Haas RL, van Coevorden F.

Ann Surg Oncol. 2010 Mar;17(3):686-93. doi: 10.1245/s10434-009-0806-9.

18.

Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures.

Daigeler A, Klein-Hitpass L, Chromik MA, Müller O, Hauser J, Homann HH, Steinau HU, Lehnhardt M.

BMC Cancer. 2008 Oct 29;8:313. doi: 10.1186/1471-2407-8-313.

19.

Pleomorphic liposarcoma of the foot: a case report.

Brcić L, Jakovcević A, Vuletić LB, Orlić D, Seiwerth S.

Diagn Pathol. 2008 Apr 16;3:15. doi: 10.1186/1746-1596-3-15.

20.

Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.

Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S.

Ann Surg. 2006 Sep;244(3):381-91.

Supplemental Content

Support Center